CGM Use in Children With Type 2 Diabetes
- Conditions
- Hyperglycemia Due to Type 2 Diabetes MellitusType 2 Diabetes
- Interventions
- Device: Continuous glucose monitor
- Registration Number
- NCT04721158
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
- Detailed Description
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for 10 days has an impact on short and long term glycemic control and behavior in youth onset Type 2 diabetes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 41
- Type 2 diabetes, diabetes duration >3 months
- Prior use of CGM
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description CGM Arm Continuous glucose monitor Children with type 2 diabetes will wear a continuous glucose monitor for 10 days.
- Primary Outcome Measures
Name Time Method Percentage of Time in Range Glucose Control 5 days, 10 days The percentage of total time that the patient uses the continuous glucose monitor (CGM) where the blood glucose falls between 70 and 180 mg/dL
Hemoglobin A1c Baseline, 3 - 6 months HbA1c at baseline and 3-6 month follow-up.
More Frequent Glycemic Control Monitoring 10 days Response to "Do you look at or check your blood sugar more often than before?"
More Frequent Insulin Administration 10 days from CGM placement Response to "Did you take your insulin more often than before?"
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Johns Hopkins Pediatric Diabetes Center
🇺🇸Baltimore, Maryland, United States